{"id":4379,"date":"2025-08-29T10:54:49","date_gmt":"2025-08-29T07:54:49","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4379"},"modified":"2025-08-29T10:54:51","modified_gmt":"2025-08-29T07:54:51","slug":"santhera-enters-into-agreement-with-ikris-pharma-network-for-the-distribution-of-agamree-vamorolone-in-india","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/es\/santhera-enters-into-agreement-with-ikris-pharma-network-for-the-distribution-of-agamree-vamorolone-in-india\/","title":{"rendered":"Santhera firma un acuerdo con Ikris Pharma Network para la distribuci\u00f3n de AGAMREE (vamorolone) en India."},"content":{"rendered":"<p class=\"wp-block-paragraph\">Santhera Pharmaceuticals anuncia la firma de un acuerdo exclusivo con Ikris Pharma Network (Ikris) para gestionar la distribuci\u00f3n de AGAMREE (vamorolone) en India, para el tratamiento de la distrofia muscular de Duchenne (DMD) en pacientes de cuatro a\u00f1os de edad y mayores.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Leer m\u00e1s:&nbsp;<a href=\"https:\/\/dmdwarrior.com\/es\/what-is-agamree-vamorolone-what-is-agamree-used-for\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00bfQu\u00e9 es Agamree (vamorolone)? \u00bfPara qu\u00e9 se utiliza Agamree?<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El acuerdo entre Santhera e Ikris tiene una vigencia de 5 a\u00f1os y Santhera recibir\u00e1 un porcentaje de las ventas netas, de acuerdo con acuerdos de distribuci\u00f3n anteriores. Se espera que las ventas comiencen en el cuarto trimestre de 2025, con base en pacientes designados.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dario Eklund, director ejecutivo de Santhera, dijo<\/strong>Nos complace asociarnos con Ikris Pharma Network en India, lo cual forma parte de nuestra estrategia m\u00e1s amplia para ampliar el acceso global a AGAMREE para pacientes con DMD. Ikris ha trabajado activamente en el \u00e1rea de la DMD y su experiencia y dedicaci\u00f3n para garantizar que los medicamentos para enfermedades raras lleguen a los pacientes los convierte en un socio ideal en la regi\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">M\u00e1s informaci\u00f3n:&nbsp;<a href=\"https:\/\/dmdwarrior.com\/es\/miraculous-steroid-vamorolone-agamree-could-offer-safer-treatment-for-dmd\/\" target=\"_blank\" rel=\"noreferrer noopener\">El esteroide milagroso vamorolone (Agamree) podr\u00eda ofrecer un tratamiento m\u00e1s seguro para la DMD<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Praveen Sikri, fundador y director ejecutivo de Ikris Pharma Network, dijo<\/strong>Esta colaboraci\u00f3n con Santhera se alinea con nuestro objetivo de abordar las necesidades m\u00e9dicas no cubiertas en la comunidad de enfermedades raras. Esperamos aprovechar nuestra red de distribuci\u00f3n para ayudar a los pacientes con DMD en India a acceder a este tratamiento transformador.<\/p>","protected":false},"excerpt":{"rendered":"<p>Santhera Pharmaceuticals announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE (vamorolone) in India, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older. Read More:&nbsp;What is Agamree (vamorolone)? What is Agamree Used For? The agreement between Santhera and Ikris [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4380,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,407,83,212,43],"class_list":["post-4379","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-ikris-pharma-network","tag-india","tag-steroid","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/4379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=4379"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/4379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/4380"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=4379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=4379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=4379"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}